Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2009
10/06/2009US7598251 aminopyrazine derivatives; ROCK inhibitors; 3-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)pyrazin-2-amine; antiinflammatory, antidiabetic, antiproliferative agents
10/06/2009US7598250 for treating neurodegenerative disease such as Alzheimer's disease
10/06/2009US7598245 Pyruvate dehydrogenase kinase, c-KIT, cyclin-dependent kinases, Janus kinases, FLT3 kinase, AUR-2 kinase, tyrosine kinase; 1-(2-amino-4-pyridyl)-3-phenylaminotriazoles; combination therapy with antiallergens, immunomodulators, antiproliferative agents; Alzheimer's, Parkinson's, Multiple Sclerosis, asthma
10/06/2009US7598242 Compounds for the treatment of inflammatory disorders
10/06/2009US7598236 Diazabicyclic central nervous system active agents
10/06/2009US7597955 Light-emitting device, organic compound and display
10/06/2009CA2488034C Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues
10/06/2009CA2402431C 1,2,3,4-tetrahydroisoquinoline derivatives
10/06/2009CA2301377C N-aroylphenylalanine derivatives
10/01/2009WO2009120094A2 Substituted pyrimidines and triazines and their use in cancer therapy
10/01/2009WO2009119880A1 Substituted pyrazole derivatives and use thereof
10/01/2009WO2009119869A1 Acenaphthopyridine derivative, material of light-emitting element, light-emitting element, light-emitting device, and electronic appliance
10/01/2009WO2009119776A1 Fused heterocyclic derivative and use thereof
10/01/2009WO2009119726A1 Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor
10/01/2009WO2009119537A1 Hydroxyquinoxalinecarboxamide derivative
10/01/2009WO2009119534A1 Novel tetrahydroisoquinoline derivative
10/01/2009WO2009119167A1 Aniline derivative having anti-rna viral activity
10/01/2009WO2009119163A1 Compound for organic electroluminescent device and organic electroluminescent device using the same
10/01/2009WO2009119088A1 Heterocyclic compound
10/01/2009WO2009118765A2 Novel monoamine re-uptake inhibitor
10/01/2009WO2009118384A1 Quinazolinone derivatives as tubulin polymerization inhibitors
10/01/2009WO2009118382A1 Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors
10/01/2009WO2009118370A1 Aza-bicyclohexyl substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
10/01/2009WO2009118305A1 Hydroxamate-based inhibitors of deacetylases b
10/01/2009WO2009118254A1 Aminopiperidinyl derivatives and uses thereof
10/01/2009WO2009118163A1 (hetero-)aryl cyclohexane derivatives
10/01/2009WO2009117985A1 Pirinixic acid derivatives as prostglandin e2 synthesis inhibitors for treating inflammatory diseases
10/01/2009WO2009117808A1 Inhibitors of histone deacetylase
10/01/2009WO2009095399A3 Pyrazine derivatives and their use as protein kinase inhbitors
10/01/2009WO2009080555A3 Carboxyl- or hydroxyl- substituted benzimidazole derivatives
10/01/2009WO2009079797A9 Compounds and method for treatment of cancer
10/01/2009WO2009079767A9 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer
10/01/2009WO2009074300A3 Hedgehog pathway antagonists and therapeutic applications thereof
10/01/2009WO2009065919A3 Organic compounds
10/01/2009WO2009056707A3 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof
10/01/2009WO2008147763A8 Mmp inhibitors and methods of use thereof
10/01/2009US20090247752 Gatifloxacin-containing aqueous liquid preparation, its production and method for suppressing formation of precipitate during storage at lower temperature and at the time of freezing and thawing of the aqueous liquid preparation
10/01/2009US20090247731 Boronic ester and acid compounds, synthesis and uses
10/01/2009US20090247717 New dinitro compound and its corresponding diamine containing heterocyclic thermal stable compound and organosoluble polyimide and polyimide copolymer
10/01/2009US20090247586 Carboxamides for controlling micro-organisms in plant and material protection
10/01/2009US20090247578 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials
10/01/2009US20090247577 Pyrrolidine derivatives useful as bace inhibitors
10/01/2009US20090247574 3-amino-pyridine derivatives for the treatment of metabolic disorders
10/01/2009US20090247573 (hetero)aryl cyclohexane derivatives
10/01/2009US20090247560 Diaryl ketimine derivative
10/01/2009US20090247550 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as hdl-cholesterol raising agents
10/01/2009US20090247547 Hydroxamate-based inhibitors of deacetylases b
10/01/2009US20090247542 Syntheses and preparations of polymorphs of crystalline aripiprazole
10/01/2009US20090247541 Novel compounds
10/01/2009US20090247534 New compounds
10/01/2009US20090247525 Sigma receptor inhibitors
10/01/2009US20090247523 Carboxamide 4-[(4-pyridyl)amino]pyrimidines useful as hcv inhibitors
10/01/2009US20090247513 Benzothiophene compounds having antiinfective activity
10/01/2009US20090247510 Use Of Irbesartan For The Preparation Of Medicinal Products That Are Useful For Preventing or Treating Pulmonary Hypertension
10/01/2009US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders
10/01/2009US20090247508 Benzoimidazole Compounds
10/01/2009US20090247499 Sulfonylated piperazines as cannabinoid-1 receptor modulators
10/01/2009US20090247474 3-Aminopyrrolidine Derivatives As Modulators Of Chemokine Receptors
10/01/2009US20090246169 Indolopyridines as eg5 kinesin modulators
10/01/2009US20090242837 Charge transport compositions and electronic devices made with such compositions
10/01/2009CA2719477A1 Hydroxamate-based inhibitors of deacetylases b
10/01/2009CA2719394A1 Hydroxyquinoxalinecarboxamide derivative
10/01/2009CA2718727A1 Heterocyclic compound
10/01/2009CA2718209A1 (hetero)aryl cyclohexane derivatives
10/01/2009CA2717384A1 Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism
10/01/2009CA2716932A1 Aza-bicyclohexyl substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
10/01/2009CA2716726A1 Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors
10/01/2009CA2716088A1 Quinazolinone derivatives as tubulin polymerization inhibitors
10/01/2009CA2712468A1 Aminopiperidinyl derivatives and uses thereof
09/2009
09/30/2009EP2105441A1 Alanyl aminopeptidase and dipeptidylpeptidase IV dual inhibitors for the treatment of immunological, inflammatory, neuronal and other illnesses
09/30/2009EP2105436A1 Lactam-containing compounds and derivatives thereof as factor XA inhibitors
09/30/2009EP2105136A2 Pharmaceutical compositions for treating cancer
09/30/2009EP2105135A2 Pharmaceutical compositions for treating cancer
09/30/2009EP2104673A2 New 2, 4-dianilinopyrimidines, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
09/30/2009EP2104672A2 2-(piperidin-4-yl0xy)pyrimidin-4-amine derivatives as deoxycytidine kinase inhibitors for the treatment of cancer
09/30/2009EP2104671A2 Substituted heterocyclylcarbonylamino-acetic-acid-derivatives as inhibitors of bacterial heptose synthesis, methods for their preparation and biological applications of said inhibitors
09/30/2009EP2104670A2 Novel triazinedione derivatives as gaba-b receptor modulators
09/30/2009EP2104669A2 Inhibitors of akt activity
09/30/2009EP1962849B1 Quinoline derivatives useful in the treatment of mglur5 receptor-mediated disorders
09/30/2009EP1768667B1 Cannabinoid receptor ligands
09/30/2009EP1711181B1 Quinoline derivatives and use thereof as mycobacterial inhibitors
09/30/2009EP1581523B1 Pyrazole-derivatives as factor xa inhibitors
09/30/2009EP1553089B1 Antagonist of melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient
09/30/2009EP1435944B1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
09/30/2009CN101547916A mGluR5 modulators
09/30/2009CN101547915A Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists
09/30/2009CN101547914A Indoles compound
09/30/2009CN101544630A Hydroxylated indinavir, preparation method of hydroxylated indinavir, and application of hydroxylated indinavir in preparation of antimalarials
09/30/2009CN101544604A Tricyclic compounds
09/30/2009CN101544592A N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
09/30/2009CN100545161C Heterocyclic derivatives their preparing methods and uses
09/30/2009CN100545160C Diamine derivatives
09/29/2009US7595399 Tyrosine derivatives
09/29/2009US7595343 Inhibitors of histone deacetylase
09/29/2009US7595339 Such as N-(4-Fluoro-benzyl)-4-(3-phenyl-indole-1-sulfonyl)-benzamide; Cannabinoid-1 (CB1) receptor; dietetics
09/29/2009US7595336 Isatine derivatives with neurotrophic activity
09/29/2009US7595332 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity
09/29/2009US7595329 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; gastroesophageal reflux disease, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability
09/29/2009US7595323 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
09/29/2009US7595321 Useful for the prevention and/or treatment of cognitive disorders; 3-Amino-N-(2-cyanoethyl)-6-[4-(pyrrolidin-1-ylsulfonyl)phenyl]pyrazine-2-carboxamide, for example
1 ... 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 ... 1080